BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,186,000 | +29.3% | 10,000 | +51.5% | 0.17% | +23.6% |
| Q3 2021 | $917,000 | -41.0% | 6,600 | -58.8% | 0.14% | -68.3% |
| Q2 2021 | $1,553,000 | -49.5% | 16,000 | -64.4% | 0.44% | -40.5% |
| Q1 2021 | $3,076,000 | +187.2% | 45,001 | +260.0% | 0.74% | +146.8% |
| Q4 2020 | $1,071,000 | – | 12,500 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |